Skip Navigation

FDA moves closer to sickle cell cure that uses gene editing

www.nbcnews.com FDA moves closer to sickle cell cure that uses gene editing

If approved by the FDA, it would be the first medication on the market that uses the groundbreaking gene-editing tool CRISPR.

FDA moves closer to sickle cell cure that uses gene editing
5
5 comments